BRIEF — New Tremfya® Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups

Oct 12 (Reuters) — Johnson & Johnson: New Tremfya® (Guselkumab) Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups Source text:... Further company coverage: JNJ.N (Reuters.Briefs@thomsonreuters.com;)